In the aftermath of the initial discovery that Myc is the cellular homolog of the retroviral v-Myc oncogene (53), little more than a year elapsed before recognizing that the former was commonly rearranged, amplified, and/or otherwise deregulated in human cancers, most notably Burkitt’s lymphoma (54–62). Here, MYC is linked to cancer.